Back to Search
Start Over
Pembrolizumab-Induced Rhabdomyolysis With Myositis in a Patient With Lung Adenocarcinoma.
- Source :
-
Archivos de bronconeumologia [Arch Bronconeumol (Engl Ed)] 2018 Jun; Vol. 54 (6), pp. 346-348. Date of Electronic Publication: 2018 Feb 26. - Publication Year :
- 2018
- Subjects :
- Adenocarcinoma
Adenocarcinoma of Lung complications
Aged, 80 and over
Antibodies, Monoclonal, Humanized therapeutic use
Antineoplastic Agents, Immunological therapeutic use
Blepharoptosis chemically induced
Deglutition Disorders chemically induced
Humans
Male
Neoplasms, Second Primary complications
Prednisone therapeutic use
Prostatic Neoplasms
Adenocarcinoma of Lung drug therapy
Antibodies, Monoclonal, Humanized adverse effects
Antineoplastic Agents, Immunological adverse effects
Lung Neoplasms complications
Myositis chemically induced
Neoplasms, Second Primary drug therapy
Rhabdomyolysis chemically induced
Subjects
Details
- Language :
- English; Spanish; Castilian
- ISSN :
- 2173-5751
- Volume :
- 54
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Archivos de bronconeumologia
- Publication Type :
- Academic Journal
- Accession number :
- 29496287
- Full Text :
- https://doi.org/10.1016/j.arbres.2018.01.026